Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
出版年份 2023 全文链接
标题
Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-01-06
DOI
10.3389/fendo.2022.1056562
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Non‐alcoholic fatty liver disease and type 2 diabetes: An update
- (2022) Chi‐H Lee et al. Journal of Diabetes Investigation
- Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease among 73,566 Individuals in Beijing, China
- (2022) Qianli Yuan et al. International Journal of Environmental Research and Public Health
- Metabolic dysfunction-associated fatty liver disease — How relevant is this to primary care physicians and diabetologists?
- (2022) Chi-Ho Lee Primary Care Diabetes
- Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis
- (2022) Stefano Ciardullo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetes Liver Fibrosis Score to Detect Advanced Fibrosis in Diabetics with Non-alcoholic Fatty Liver Disease
- (2021) Amandeep Singh et al. Clinical Gastroenterology and Hepatology
- Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults
- (2021) Jiaye Liu et al. Clinical Gastroenterology and Hepatology
- Development of a Non-Invasive Liver Fibrosis Score Based on Transient Elastography for Risk Stratification in Patients with Type 2 Diabetes
- (2021) Chi-Ho Lee et al. Endocrinology and Metabolism
- Liver Fibrosis in Asians With Metabolic Dysfunction–Associated Fatty Liver Disease
- (2021) Won Sohn et al. Clinical Gastroenterology and Hepatology
- Metabolic dysfunction associated fatty liver disease improves detection of high liver stiffness: The rotterdam study
- (2021) Laurens van Kleef et al. HEPATOLOGY
- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update
- (2021) Annalisa Berzigotti et al. JOURNAL OF HEPATOLOGY
- An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD
- (2021) Grace En Hui Lim et al. Clinical Gastroenterology and Hepatology
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta‐analysis: Focusing on the non‐overlap groups
- (2021) Ibrahim Ayada et al. LIVER INTERNATIONAL
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- (2021) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- Non‐invasive tests for liver fibrosis in NAFLD: Creating pathways between primary healthcare and liver clinics
- (2020) Laurent Castera LIVER INTERNATIONAL
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
- (2020) Helen Jarvis et al. PLOS MEDICINE
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- Cohort profile: The Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) and the follow-up studies
- (2020) David Tak Wai Lui et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease
- (2020) Margarita Papatheodoridi et al. JOURNAL OF HEPATOLOGY
- Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease
- (2020) Vincent Wai-Sun Wong et al. Clinical Gastroenterology and Hepatology
- Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
- (2019) Fernando Bril et al. DIABETES CARE
- Independent association of serum vitamin D with anti-Mullerian hormone levels in women with polycystic ovary syndrome
- (2018) Ho Yan Queenie Wong et al. CLINICAL ENDOCRINOLOGY
- Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
- (2018) Eduardo Vilar-Gomez et al. JOURNAL OF HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
- (2017) Anna M. Diehl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Predicting Fibrosis Worsening in Obese Patients With NASH Through Parenchymal Fibronectin, HOMA-IR and Hypertension
- (2009) Paolo Sorrentino et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search